Endo International plc (NASDAQ:ENDP) announced that one of its operating companies, Par Pharmaceutical has received final approval from the U.S.
Endo International plc – Ordinary Shares (NASDAQ:ENDP) and the U.S.
Endo International plc – Ordinary Shares (NASDAQ: ENDP) announced that it has appointed Blaise Coleman as Executive Vice President and Chief Financial Officer, …
Endo International plc – Ordinary Shares (NASDAQ:ENDP) announced that one of its operating companies, Par Pharmaceutical, has begun shipping ezetimibe 10 mg tablets, …
Endo International plc – Ordinary Shares (NASDAQ:ENDP) announced that it has entered into an agreement with its partner, BioDelivery Sciences International, Inc. (BDSI), to return …
Endo International plc – Ordinary Shares (NASDAQ:ENDP) announced that one of its operating companies, Par Pharmaceutical, has begun shipping mycophenolate mofetil hydrochloride (HCl) …
JMP analyst Donald Ellis is encouraged on Endo International plc – Ordinary Shares (NASDAQ:ENDP) after the biotech firm’s pipeline drug Xiaflex, used to …
Endo International plc – Ordinary Shares (NASDAQ:ENDP) announced today positive results from its Phase 2b study of collagenase clostridium histolyticum (or “CCH”) for …
Amid President Elect Donald Trump’s victory, stocks in the biotech sector are on an upturn now that the Clinton Administration will not be …
Endo International plc – Ordinary Shares (NASDAQ:ENDP) reported third quarter 2016 financial results, including: Revenues of $884 million including the addition of sales …